Publicaciones (145) Publicaciones de MIGUEL MINGUEZ PEREZ

2024

  1. Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry

    Therapeutic Advances in Gastroenterology, Vol. 17

2023

  1. Biological treatment interruption in inflammatory bowel disease: Motivation and predictive factors

    Gastroenterologia y Hepatologia, Vol. 46, Núm. 9, pp. 671-681

  2. I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease

    Clinical Gastroenterology and Hepatology, Vol. 21, Núm. 3, pp. 771-788.e10

2022

  1. Adherence to endoscopic surveillance for advanced lesions and colorectal cancer in inflammatory bowel disease: an AEG and GETECCU collaborative cohort study

    Alimentary pharmacology & therapeutics, Vol. 55, Núm. 11, pp. 1402-1413

  2. Autoimmune hepatitis triggered by COVID-19

    Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, Vol. 114, Núm. 1, pp. 64-65

  3. Caustic Ingestion: A Risk-Based Algorithm

    The American journal of gastroenterology, Vol. 117, Núm. 10, pp. 1593-1604

  4. Evaluation of Expanded Criteria Donors Using the Kidney Donor Profile Index and the Preimplantation Renal Biopsy

    Transplant International, Vol. 35

  5. Intolerancias alimenticias.

    Anales (Reial Acadèmia de Medicina de la Comunitat Valenciana), Núm. 22

  6. Long-term evolution of continence and quality of life after sphincteroplasty for obstetric fecal incontinence

    Annals of Coloproctology, Vol. 38, Núm. 1, pp. 13-19

  7. Management of patients with Intestinal Bowel Disease and COVID-19: A review of current evidence and future perspectives

    Gastroenterologia y Hepatologia, Vol. 45, Núm. 5, pp. 383-389

  8. Performance of Screening Strategies for Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease: Results from the ENEIDA Registry of GETECCU

    Journal of Clinical Medicine, Vol. 11, Núm. 13

  9. Reply

    Diseases of the Colon and Rectum

  10. Risk of Immunomediated Adverse Events and Loss of Response to Infliximab in Elderly Patients with Inflammatory Bowel Disease: A Cohort Study of the ENEIDA Registry

    Journal of Crohn's & colitis, Vol. 16, Núm. 6, pp. 946-953

  11. Surgical Wound Dehiscence in Kidney Transplantation: Risk Factors and Impact on Graft Survival

    Transplantation Proceedings, Vol. 54, Núm. 1, pp. 27-31

  12. Thiopurine adherence: a high prevalence with low impact on UC outcomes

    Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, Vol. 114, Núm. 2, pp. 76-82

  13. Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial

    The Lancet Gastroenterology and Hepatology, Vol. 7, Núm. 4, pp. 294-306

2021

  1. Botulinum Toxin Injection Plus Topical Diltiazem for Chronic Anal Fissure: A Randomized Double-Blind Clinical Trial and Long-term Outcome

    Diseases of the colon and rectum, Vol. 64, Núm. 12, pp. 1521-1530

  2. Caustic ingestion: Development and validation of a prognostic score

    Endoscopy, Vol. 53, Núm. 8, pp. 784-791

  3. Effectiveness and Safety of Ustekinumab in Ulcerative Colitis: Real-world Evidence from the ENEIDA Registry

    Journal of Crohn's and Colitis, Vol. 15, Núm. 11, pp. 1846-1851

  4. Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: Study Based on the ENEIDA Registry

    Digestive Diseases and Sciences, Vol. 66, Núm. 6, pp. 2014-2023